Award recordCONTRACT

PRIORITY HEALTHCARE DISTRIBUTION INC

PIID 36C25619P1307· VHA· 256-NETWORK CONTRACT OFFICE 16 (36C256)· 6505 · DRUGS AND BIOLOGICALS· FY2019· $283,568 net obligations· UEI JCVFNPM8CNS3· FL

Description

KYMRIAH (TISAGENLECLECUCEL) TO TREAT CANCER PATIENTS 10-50ML.

First action · last action
2019-07-25 · 2019-07-25
Transactions
1
First transaction's obligation
$283,568
Base + all options value (sum of deltas)
$283,568
Extent competed
NOT COMPETED UNDER SAP
Other than full & open authority
SAP NON-COMPETITION (FAR 13)
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 1 transaction

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$283,568$0Base award · 2019-07-25 · this action $283,568 · running total $283,568
  • Base2019-07-25+$283,568= $283,568
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2019-07-25+$283,568$283,568KYMRIAH (TISAGENLECLECUCEL) TO TREAT CANCER PATIENTS 10-50ML.

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI JCVFNPM8CNS3)

AwardOffice · PSC / listingNet obligationsFY
36C24226P0942242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS$15,746FY2026
36C24226P0847242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS$15,746FY2026
36C24226P0786242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS$15,746FY2026
36C24226P0705242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS$15,746FY2026
36C24226P0630242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS$17,614FY2026
36C24226P0547242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS$15,746FY2026

Other recipients under 6505 from 256-NETWORK CONTRACT OFFICE 16 (36C256) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C25626N0555CARDINAL HEALTH 414, LLC256-NETWORK CONTRACT OFFICE 16 (36C256)$654,692FY2026
36C25626P0618HANGER PROSTHETICS & ORTHOTICS INC256-NETWORK CONTRACT OFFICE 16 (36C256)$15,119FY2026
36C25626N0492BAYER HEALTHCARE PHARMACEUTICALS INC256-NETWORK CONTRACT OFFICE 16 (36C256)$386,860FY2026
36C25626N0469CARDINAL HEALTH 414, LLC256-NETWORK CONTRACT OFFICE 16 (36C256)$396,000FY2026
36C25626N0461CARDINAL HEALTH 414, LLC256-NETWORK CONTRACT OFFICE 16 (36C256)$271,226FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C25619P1307_3600_-NONE-_-NONE- · retrieved 2026-09-26.